ArticleACS central science2025
Engineering of Integral Membrane Metalloenzyme UndB and Designing of a Cell-Free Biocatalytic Platform Enabled Efficient 1‑Alkene Production.
Article in ACS central science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In the Marathon toward Achieving Efficient Enzymatic Decarboxylation of Fatty Acids.ACS central science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bioproduction of 1-alkenes is of significant global interest due to their potential as green commodity chemicals and next-generation 'drop-in' biofuels. Here, we report an engineering strategy to enhance the catalytic activity and substrate specificity of the membrane-bound metalloenzyme UndB, significantly improving its utility in biocatalytic 1-alkene production. We developed a highly efficient UndB-based cell-free biocatalytic platform for high-yield medium-chain 1-alkene production. This system achieved a 262-fold improvement in UndB activity toward 1-undecene production, with a total turnover of 3412. Through structural analysis of the UndB family of proteins, we engineered UndB by domain-swapping, enhancing its selectivity toward naturally abundant long-chain fatty acids, enabling efficient long-chain 1-alkene production. Our large-scale simulations unveiled a crucial ion-pair network that orchestrates substrate-protein interactions, providing a framework for substrate stabilization. We identified a highly dynamic and functionally pivotal Arg121 residue that governs substrate uptake and stabilization, providing mechanistic insights into UndB's substrate recognition. Furthermore, simulations revealed that precise modulation of the substrate-binding pocket volume serves as the key determinant of substrate specificity across UndB variants, offering insights into the evolutionary adaptability of the UndB family. Our system achieved 98% 1-alkene yield using only 0.04 mol % catalyst loading under mild conditions, presenting a promising bioproduction strategy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.